Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Lane
Deirdre
D
Lip
Gregory Y H
GY
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D016903:Drug Monitoring; D006801:Humans; D019934:International Normalized Ratio; D008875:Middle Aged; D017060:Patient Satisfaction; D011788:Quality of Life; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin